Cargando…
FX5 as a non-steroidal GR antagonist improved glucose homeostasis in type 2 diabetic mice via GR/HNF4α/miR-122-5p pathway
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by glucose metabolic disorders, and gluconeogenesis inhibiting is a promisingly therapeutic strategy for T2DM. Glucocorticoid receptor (GR) is tightly implicated in the regulation of gluconeogenesis, although the underlying...
Autores principales: | Xu, Xin, Chen, Yidi, Zhu, Danyang, Zhao, Tong, Xu, Rui, Wang, Jiaying, Hu, Lihong, Shen, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880398/ https://www.ncbi.nlm.nih.gov/pubmed/33316780 http://dx.doi.org/10.18632/aging.202275 |
Ejemplares similares
-
GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life
por: Louw, Ann
Publicado: (2019) -
Discovery of Novel GR Ligands toward Druggable GR Antagonist Conformations Identified by MD Simulations and Markov State Model Analysis
por: Hu, Xueping, et al.
Publicado: (2021) -
FX5, a non-steroidal glucocorticoid receptor antagonist, ameliorates diabetic cognitive impairment in mice
por: Zhu, Dan-yang, et al.
Publicado: (2022) -
514 Role of TH-17 Cytokines in Steroid Insensitivity in Peripheral Blood Mononuclear Cells. Relationship to GR-alpha and GR-beta Expression
por: Vazquez-Tello, Alejandro, et al.
Publicado: (2012) -
Impaired Spermatogenesis and gr/gr Deletions Related to Y Chromosome Haplogroups in Korean Men
por: Choi, Jin, et al.
Publicado: (2012)